Haloperidol

Haloperidol

SCHEMBL8264

O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DRD2DRD3DRD4HTR2A

The experimentally established mechanism targets of Haloperidol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 known ✓ P14416 14/20 1.00
HTR2A known ✓ P28223 3/20 1.00
DRD3 known ✓ P35462 3/20 1.00
DRD4 known ✓ P21917 2/20 1.00
ADRA1A P35348 4/20 1.00
HTR1A P08908 3/20 1.00
ADRA2A P08913 3/20 1.00
ADRA2B P18089 3/20 1.00
ADRA2C P18825 3/20 1.00
HRH1 P35367 3/20 1.00
HTR2C P28335 2/20 1.00
ADRA1B P35368 2/20 1.00
CYP1A2 P05177 2/20 1.00
CYP3A4 P08684 2/20 1.00
CYP2D6 P10635 2/20 1.00
CHRM1 P11229 2/20 1.00
CHRM3 P20309 2/20 1.00
SLC6A2 P23975 2/20 1.00
SLC6A4 P31645 2/20 1.00
OPRM1 P35372 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Haloperidol SCHEMBL5070670 1.00 DRD2 (1.00) DRD2ADRA1AHTR1AADRA2AADRA2B
SCHEMBL20254453 1.00 DRD2 (1.00) DRD2ADRA1AHTR1AADRA2AADRA2B
Haloperidol SCHEMBL317367 0.99 DRD2 (0.98) DRD2ADRA1AHTR1AADRA2AADRA2B
Haloperidol SCHEMBL15545886 0.99 DRD2 (0.98) DRD2ADRA1AHTR1AADRA2AADRA2B
Haloperidol SCHEMBL28699132 0.98 DRD2 (0.96) DRD2ADRA1AHTR1AADRA2AADRA2B
Haloperidol SCHEMBL8741248 0.97 DRD2 (0.94) DRD2ADRA1AHTR1AADRA2AADRA2B
SCHEMBL11752117 0.97 DRD2 (1.00) DRD2ADRA1AHTR1AADRA2AADRA2B
Haloperidol SCHEMBL20644145 0.96 DRD2 (0.92) DRD2ADRA1AHTR1AADRA2AADRA2B
Haloperidol SCHEMBL9507217 0.96 DRD2 (0.92) DRD2ADRA1AHTR1AADRA2AADRA2B
SCHEMBL9054984 0.94 DRD2 (1.00) DRD2ADRA1AHTR1AADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 67125 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3607938-B1 PHARMACEUTICAL COMPOSITION SOVIC BRKICIC LJILJANA (HR) 2026-05-27 EP claimed
CN-122080363-A Room-temperature-curable epoxy resin raw material composition, room-temperature-curable epoxy resin, and preparation method and application thereof 2026-05-26 CN claimed
CN-122080590-A High-heat-conductivity low-water-absorption epoxy molding compound for semiconductors 2026-05-26 CN claimed
CN-122080734-A Coating liquid for preparing high-temperature-resistant high-heat-conductivity epoxy-based conductive film, and preparation method and application thereof 2026-05-26 CN claimed
CN-122080854-A Organosilicon modified epoxy bi-component die-bonding adhesive and preparation method thereof 2026-05-26 CN claimed
CN-122080058-A Liquid flame retardant, vacuum-infusion flame-retardant epoxy resin raw material composition, epoxy resin, and preparation method and application thereof 2026-05-26 CN claimed
CN-122094963-A Cardioprotective lipids and methods of use 2026-05-26 CN claimed
CN-122079934-A Pinonic acid modified epoxy resin, preparation method thereof, extremely applicable high-elasticity low-temperature-resistant anticorrosive paint, preparation method thereof and application thereof 2026-05-26 CN claimed
CN-122080469-A Aramid fiber honeycomb wave-absorbing structural member and interface regulation and control method thereof 2026-05-26 CN claimed
CN-122091384-A Preparation method of high-temperature magnetic slurry capable of being molded at low pressure for inductor 2026-05-26 CN claimed
EP-0025546-A2 Therapeutical use of tranquillizing benzodiazepine derivatives and mixtures containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-03-25 EP claimed
EP-0022771-A4 RADIO RECEPTOR ASSAY FOR BENZODIAZEPINES IN PLASMA AND OTHER BIOLOGICAL SPECIMENS. US HEALTH (US) 1981-02-04 EP claimed
EP-0022771-A1 RADIO RECEPTOR ASSAY FOR BENZODIAZEPINES IN PLASMA AND OTHER BIOLOGICAL SPECIMENS THE UNITED STATES OF AMERICA, represented by DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1981-01-28 EP claimed
EP-0011606-A2 Pharmaceutical compositions with central depressing and antipsychotic activity CIBA-GEIGY AG (CH) 1980-05-28 EP claimed
WO-1980000750-A1 RADIO RECEPTOR ASSAY FOR BENZODIZAPINES IN PLASMA AND OTHER BIOLOGICAL SPECIMENS US COMMERCE (US) 1980-04-17 WO claimed
US-4197288-A Neuroleptic radioreceptor assay method and kit BURROUGHS WELLCOME CO. (US) 1980-04-08 US claimed
US-4175119-A Composition and method to prevent accidental and intentional overdosage with psychoactive drugs PORTER GARRY L 1979-11-20 US claimed
US-4166767-A Insolubilized antibody DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1979-09-04 US claimed
US-4086234-A Process for the preparation of tertiary amines G. D. SEARLE & CO. (US) 1978-04-25 US claimed
US-3947579-A HALOGENATED AMINO ACID NELSON RESEARCH & DEVELOPMENT COMPANY (US) 1976-03-30 US claimed